Federal Guidelines Now Allow Self-Swab HPV Tests as Pap Alternative

A New Option for Cervical Cancer Screening

The dreaded Pap smear may soon become optional for many women. According to new recommendations released Monday by the Health Resources and Services Administration (part of the Health and Human Services Department), women ages 30 to 65 with an average risk of cervical cancer can opt for a self-administered HPV test. This groundbreaking change represents the first major shift in federal cervical cancer screening guidelines in nearly a decade.

Self-administered HPV tests involve inserting a plastic tube — similar to a tampon — into the vagina, then twisting the handle to swab for cells that can be examined in a lab. Pap smears, on the other hand, use a metal or plastic device called a speculum to widen the vaginal canal so a clinician can swab the cervix for cells. Studies have found that self-swab HPV tests are similarly accurate to the ones administered by a clinician.

Per the new recommendations, women should get an HPV test every five years, either via self-swab or administered by a clinician. Doctors should still make Pap smears available, the guidelines say, though they're no longer the preferred cervical cancer screening method for women ages 30 and up.

Addressing Barriers to Screening

The new guidelines tackle a persistent problem in women's healthcare. Specifically, women report experiencing pain, nervousness, and discomfort with the speculum during the screening, and 32% report delaying their screening because of discomfort alone. About half of women diagnosed with cervical cancer have either never been screened or their screening isn't up to date, and about one in four women in the U.S. are not up to date with screening, according to the CDC.

In an editorial published Monday in the Journal of the American Medical Association, federal health officials said the new guidelines could help increase screening rates, particularly for women in rural areas or those who don't have easy access to health clinics or doctor's offices. Experts are optimistic that promoting a more comfortable, less stressful option will increase screening rates, especially for women living in rural areas who do not have accessible health care clinics within their area. It is predicted that across all racial and ethnic groups, screening engagement can increase by up to 20% from where adherence rates are currently.

Rising Cancer Rates Despite Prevention Tools

The test detects human papillomavirus, which causes cervical cancer — a disease that claims more than 4,000 lives each year in the U.S. Paradoxically, while cervical cancer is highly preventable, rates are increasing year over year among women in their 30s and early 40s — perhaps as a result of delayed screenings or missing out on HPV vaccinations, which were approved in 2006.

The vaccines can prevent more than 90% of cervical cancers, and routine screenings help detect HPV infections or precancerous cells. The new guidance reflects the latest research showing that HPV tests, compared to Pap smears, can increase the detection of abnormal cells in the cervix that may lead to cancer.

Implementation and Insurance Coverage

Insurance companies must adhere to the new screening guidelines by Jan. 1, 2027. The updated guidance also aims to reduce costs that can pile up after an abnormal screening result by clarifying what insurers must cover without cost-sharing, including follow-up testing and diagnostic evaluation such as Pap testing, biopsy, and lab work, depending on individual needs.

Since 2024, the Food and Drug Administration has approved two self-swab tests that can be used in doctors' offices, as well as an at-home test called th Teal Wand. These advances bring the United States closer to screening approaches already used successfully in countries like the Netherlands, Denmark, and Australia.

The shift toward self-collection represents more than convenience—it's a recognition that removing barriers to screening could save thousands of lives annually. As healthcare providers adapt to these new guidelines over the coming years, women will have unprecedented control over how they approach one of medicine's most important preventive measures.